Egg Effects on the Immunomodulatory Properties of HDL

NCT ID: NCT03577223

Last Updated: 2021-05-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

28 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-09-07

Study Completion Date

2019-05-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to investigate the effects of egg intake on markers of HDL function and immune inflammation in healthy adults.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

28 healthy men and women (age 18-35 years old) will be recruited to participate in a 16-week randomized crossover study. Upon enrollment, all subjects will enter a 4-week run-in egg-free period where they will refrain from consuming any egg-based foods (Period 1). Subjects will then enter the first intervention period, where they be randomly assigned to consume either 3 whole eggs/day or the equivalent amount of egg white-based egg substitute/day for 4 weeks (Period 2). Afterwards, subjects will enter a 4-week washout period where egg-based foods are restricted (Period 3), followed by a second intervention period, where they be assigned to the alternative whole egg- or egg white-based treatment for 4 weeks (Period 4). Subjects will come to the Department of Biology at Fairfield University every two weeks to check-in, and to pick up their egg products during the intervention periods. Subjects will be asked to maintain their normal diet and physical activity practices throughout all periods of the study. Subjects will complete 5-day dietary records and physical activity logs at the end of each study period.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lipid Metabolism Inflammation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Whole Eggs

Group Type EXPERIMENTAL

Whole Eggs

Intervention Type OTHER

3 whole eggs per day for 4 weeks

Egg White-Based Egg Substitute

Group Type ACTIVE_COMPARATOR

Egg White-Based Egg Substitute

Intervention Type OTHER

3-egg equivalent of egg white-based egg substitute per day for 4 weeks

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Whole Eggs

3 whole eggs per day for 4 weeks

Intervention Type OTHER

Egg White-Based Egg Substitute

3-egg equivalent of egg white-based egg substitute per day for 4 weeks

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18-35 years old
* Body mass index (BMI) \< 30 kg/m2, or \< 30% body fat for men and \< 40% body fat for women
* Willingness to consume eggs or egg whites on a daily basis during study periods

Exclusion Criteria

* \< 18 years old; \> 35 years old
* BMI ≥ 30 kg/m2, or ≥ 30% body fat for men and ≥ 40% body fat for women
* Self-reported history of diabetes mellitus, coronary heart disease, stroke, renal problems, liver disease, cancer, pregnancy or lactation, autoimmunity, chronic infections, or egg allergy
* Taking lipid-lowering medications (e.g. statins, fibrates)
* A preexisting medical condition or implanted medical device that prevents participation in bioelectrical impedance measurements of body composition
* Clinical lipid and glucose values that are highly elevated, including fasting triglycerides levels higher than 500 mg/dL, fasting glucose higher than 126 mg/dL, and plasma total cholesterol greater than 240 mg/dL
Minimum Eligible Age

18 Years

Maximum Eligible Age

35 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

United States Department of Agriculture (USDA)

FED

Sponsor Role collaborator

Fairfield University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Catherine Andersen

Associate Professor of Biology

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Catherine J Andersen, PhD, RD

Role: PRINCIPAL_INVESTIGATOR

Fairfield University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Fairfield University

Fairfield, Connecticut, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

0511

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Dairy and Inflammation Study
NCT04902417 COMPLETED NA
Healthy In-Store Marketing Study
NCT02499211 COMPLETED NA